Quotes 5-day view Delayed Nyse
10/19/2020
10/20/2020
10/21/2020
10/22/2020
10/23/2020
Date
37.77(c)
37.54(c)
37.15(c)
36.86(c)
37.17(c)
Last
11 197 193
8 140 363
11 643 964
15 048 324
12 406 749
Volume
-1.74% -0.61% -1.04% -0.78% +0.84% Change
Sales 2020
10 061 M - -
Net income 2020
429 M - -
Net Debt 2020
7 266 M - -
P/E ratio 2020
125x
Yield 2020
-
Sales 2021
11 945 M - -
Net income 2021
1 571 M - -
Net Debt 2021
5 213 M - -
P/E ratio 2021
33,3x
Yield 2021
-
Capitalization
53 178 M 53 178 M -
EV / Sales 2020
6,01x
EV / Sales 2021
4,89x
Nbr of Employees
36 000
Free-Float
85,0%
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (61.1%): products used in cardiology surgeries (42.9% of net sales), cardiac rhythm management (29.6%), peripheral surgeries (21.2%), and other (6.4%);
- endodontic surgery (30.8%): equipment used in endoscopy (57.3% of net...
Notations Surperformance© of Boston Scientific Corporation
Trading Rating : Investor Rating :
All news about BOSTON SCIENTIFIC CORPORATION
News in other languages on BOSTON SCIENTIFIC CORPORATION
Chart BOSTON SCIENTIFIC CORPORATION
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends BOSTON SCIENTIFIC CORPORATION
Short Term Mid-Term Long Term Trends Bearish Neutral Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
27
Average target price
46,31 $
Last Close Price
37,17 $
Spread / Highest target
34,5%
Spread / Average Target
24,6%
Spread / Lowest Target
15,7%
Please enable JavaScript in your browser's settings to use dynamic charts.
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
